Skip to main content

Table 1 Description of the DELCODE sample at baseline

From: Neuropsychiatric symptoms in at-risk groups for AD dementia and their association with worry and AD biomarkers—results from the DELCODE study

 

Total (n = 687)

CO (n = 209)

SCD (n = 242)

MCI (n = 115)

AD (n = 77)

REL (n = 44)

F value/χ2 value

Sex (female), n (%)

351 (51.1)

120 (57.4)

117 (48.3)

42 (36.5)**

43 (55.8)

29 (65.9)

18.4, p = .001

Age, mean (SD)

70.4 (5.9)

68.8 (5.3)

71.1 (5.7)***

72.1 (5.3)***

73.7 (6.7)***

64.6 (3.9)***

27.32 p < .001

Education years, mean (SD)

14.4 (3.0)

14.8 (2.8)

14.8 (3.1)

14.0 (3.0)

13.2 (3.3)**

14.1 (2.6)

5.72, p < .001

MMSE score, mean (SD)

28.4 (2.4)

29.4 (0.9)

29.2 (1.1)

27.8 (1.8)***

23.5 (3.1)***

29.3 (1.1)

251.02, p < .001

Expresses worry about memory (ECog), n (%)

386 (58.7)

27 (13.2)

193 (83.2)***

93 (85.3)***

56 (80.0)***

17 (39.5)***

282.73, p < .001

MEM, mean (SD)

4.02 × 10−7 (0.98)

0.60 (0.39)

0.34 (0.47)***

−0.68 (0.67)***

−1.99 (0.62)***

0.51 (0.61)

446.38, p < .001

CSF biomarkers

n = 317

n = 76

n = 104

n = 74

n = 39

n = 24

 

 Aß42 (pg/ml), mean (SD)

677.7 (317.3)

851.8 (301.6)

715.5 (310.6)*

568.4 (278.8)***

390.5 (137.2)***

767 (289.9)

20.98, p < .001

 Aß42 < 496 pg/ml (n, %)

110 (34.7)

10 (13.2)

25 (24.0)

39 (52.7)***

31 (79.5)***

5 (20.8)

67.93, p < .001

 t-tau (pg/ml), mean (SD)

489.8 (265.5)

389.9 (160.1)

408.4 (192.2)

556.2 (258.7)***

844.8 (338.8)***

372.8 (103.9)

35.85, p < .001

 t-tau > 470 pg/ml, n (%)

127 (40.2)

18 (24.0)

31 (29.9)

40 (54.1)***

34 (87.2)***

4 (16.7)

60.11, p < .001

 p-tau 181 (pg/ml), mean (SD)

60.4 (30.3)

51.3 (18.4)

51.73 (23.9)

67.4 (31.8)**

96.1 (38.6)***

46.8 (12.3)

24.87, p < .001

 p-tau 181 > 57 pg/ml, n (%)

135 (44.4)

24 (31.6)

30 (30.6)

43 (61.4)**

33 (86.8)***

5 (22.7)

52.74, p < .001

  1. Bonferroni-adjusted post hoc p values in comparison to the control group: *p < .0125, **p < .003, ***p < .0003
  2. Aβ42 beta-amyloid 42, AD Alzheimer’s disease, CSF cerebrospinal fluid, ECog Everyday Cognition scale, CO healthy controls, MCI mild cognitive impairment, MEM memory factor score, MMSE Mini-Mental-State Examination, p-tau phospho-tau, REL first-degree relatives of AD patients, SCD subjective cognitive decline, SD standard deviation, t-tau total tau